Meloxicam is an enolcarboxamide with preferential COX-2 inhibitory activity. In vitro studies with human tissues have confirmed the high affinity of meloxicam for COX-2, whereas COX-1 was ...

Cyclo-oxygenase 2 (COX2) has a key proinflammatory role in the liver; however, it was not previously known whether COX2 activity alone was sufficient to induce hepatitis. Now, Yu and colleagues ...

As a COX-1 and COX-2 inhibitor, it has shown potential for reducing polyp recurrence and colorectal cancer risk in hereditary syndromes, with evidence well supported by prior randomized trials.

Enveric Biosciences (ENVB) announces that its wholly-owned subsidiary, Akos Biosciences has entered into two licensing agreements with ...

Meloxicam is well absorbed after oral administration, with an absolute bioavailability of 89% that is not markedly affected by concomitant intake of food. Meloxicam reaches maximum plasma ...